{"schema_version":"secwatch.filing_event.v1","accession":"0001140859-25-000128","form_type":"8-K","ticker":"COR","cik":"0001140859","company_name":"Cencora, Inc.","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.880336+00:00","generated_at":"2026-05-17T00:11:14.064960+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cencora Q4 adj EPS $3.84 (+15%); revenue $83.7B; raises dividend 9%; new segment structure","bullets":["Q4 GAAP diluted EPS $(1.75) (prior yr $0.02); adjusted EPS $3.84 (+15% YoY); revenue $83.7B (+5.9%).","FY2025 revenue $321.3B (+9.3%); GAAP EPS $7.96; adjusted EPS $16.00 (+16.3%).","Quarterly dividend increased 9%; long-term guidance raised.","New reporting structure Q1 FY26: U.S. Healthcare Solutions, Intl Healthcare Solutions, Other (under strategic review: MWI, Profarma, U.S. Consulting).","U.S. Healthcare Solutions FY2025 op income $3.28B (1.15% margin); Intl Healthcare op income $588M (2.07%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001140859-25-000128","json":"https://secwatch.observer/filing/0001140859-25-000128.json","markdown":"https://secwatch.observer/filing/0001140859-25-000128.md","text":"https://secwatch.observer/filing/0001140859-25-000128.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1140859/000114085925000128/0001140859-25-000128-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1140859/000114085925000128/abc-20251105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:11:14.064960+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}